Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,020 public trials 2,031 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies

NCT03088878

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +22 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Sanford Stem Cell Clinical Center at UCSD La Jolla, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View Trial Details
Completed

Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients

NCT03792763

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin V Hämatologie und Onkologie Innsbruck, Austria
  • LKH Hochsteiermark, Standort Leoben, Abteilung für Innere Medizin und Hämatologie und internistische Onkologie Leoben, Austria
View Trial Details
Completed

A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment

NCT02927769

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Children'S Hospital Phoenix, Arizona, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Valley Children's Hospital Madera, California, United States
View all 79 locations
View Trial Details
Completed

Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma

NCT04102150

Conditions
Adult T-Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Ehime University Hospital Tōon-shi, Ehime, Japan
  • Kyushu University Hospital Fukuoka, Japan
View all 24 locations
View Trial Details
Completed

A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT03992339

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Anhui Province Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Chongqing Universtity Cancer Hospital Chongqing, Chongqing Municipality, China
View all 18 locations
View Trial Details
Completed

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details

Related conditions